Neuroimaging Flashcards
(335 cards)
Ventricular Anatomy

Cerebral Edema
Edema within the brain can be caused by cell death, altered capillary permeability, or hemodynamic forces.
Cytotoxic Edema
Cytotoxic edema is cell swelling caused by damaged molecular sodium-potassium ATPase ion pumps. It can affect both gray and white matter.
Cytotoxic edema is caused by cell death, mot commonly due to infarct. Water ions trapped inside swollen cells feature reduced diffusivity.
Vasogenic Edema
Vasogenic edema is interstitial edema caused by increased capillary permeability. It is seen primarily in the white matter, as there is more interstitial space.
Vasogenic edema is caused most commonly by neoplasm, infection, or infarct.
Interstitial Edema
Interstitial edema is caused by imbalances in CSF flow, most commonly due to obstructive hydrocephalus.
Interstitial edema presents on imaging as periventricular fluid, often called “transependymal flow of CSF”, even though it is unlikely that the CSF actually flows across the ependymal cells lining the ventricles.
Herniation
The total volume in the skull is fixed. Increases in intracranial pressure may lead to herniation across a dural fold.
Herniation may be due to a mass lesion (such as a neoplasm or hematoma) or may be due to edema secondary to a large stroke. Because the volume of the posterior fossa is especially limited, cerebellar infarcts are prone to herniation.

Cerebellar tonsillar herniation
Downward displacement of the cerebellar tonsils through foramen magnum causes compression of the medulla.
Compression of medullary respiratory centers is often fatal.
Basal cisterns
The basal cisterns, also known as the perimesencephalic cisterns, are CSF–filled spaces surrouding the midbrain and pons.
Compression or effacement of the basal cisterns may be a sign of the impending or actual herniation.
Blood Brain Barrier (BBB) and enhancement
Micro or macro disruption of the blood brain barrier (BBB) produces parenchymal enhancement after contrast administration, which may be secondary to infection, inflammation, neoplasm, trauma, and vascular etiologies.
The BBB is formed by astrocytic foot processes of brain capillary endothelial cells and prevents direct communication between the systemic capillaries and the protected extracellular fluid of the brain.
Several CNS regions do not have a blood brain barrier, and therefore normally enhance: Choroid plexus, Pituitary and pineal glands, Tuber cinereum (controls circadian rhythm, located in the inferior hypothalamus). Area postrema (controls vomiting, located at inferior aspect of 4th ventricle).
The dura also lacks a blood brain barrier, but does not normally enhance. This phenomenon is subsequently explened in the section on pachymeningeal (dural) enhancement.
Vascular enhancement is due to a localized increase in blood flow, which may be secondary to vasodilation, hyperemia, neovascularity, or arteriovenous shunting. On CT, the arterial phase of contrast injection (for instance a CT angiogram) mostly shows intravascular enhancement. Parenchymal enhancement, including the dural folds of the falx and tentorium, is best seen several minutes after the initial contrast bolus.
On MRI, routine contrast-enhanced sequences are obtained in the parenchymal phase, several minutes after injection. Most intracranial vascular MRI imaging is performed with a noncontrast time of flight technique.
Intracranial enhancementmay be intra- or extra-axial. Extra-axial structures that may enhance in pathologic conditions include the dura (pachymeninges) and arachnoid (leptomeninges).
Perfusion
Perfusion MR is an advanced technique where the brain is imaged repeatedly as a bolus of gadolinium contrast is injected. The principle of perfusion MR is based on the theory that gadolinium causes a magnetic field disturbance, which (counterintuitively) transiently decreases the image intensity. Perfusion images are echo-planar T2* images, which can be acquired very quickly.
Perfusion MR may be used for evaluation of stroke and tumors.
Periventricular enhancement (intra-axial)
Enhancement of the subependymal surface can be either neoplastic, infectious, or demyelinating in etiology.
Primary CNS lymphoma is a malignant B-cell neoplasm that can have diverse presentations including periventricular enhancment, solitary brain mass, or multiple brain masses.
Primary CNS lymphoma is hyperattenuating on CT and demonstrates low ADC and low signal intensity on T2-weighted MRI due to hypercellularity.
Primary CNS lymphoma rarely involves the meninges. In contrast, the meninges (both pachymeninges and leptomeninges) are commonly involved when systemic lymphoma spreads to the brain.
CNS lymphoma tends to be centrally necrotic in immunocompromised patients, but usually enhances homogeneously in immunocompetent patients.
Infectious ependymitis is most commonly caused by cytomegalovirus. Infectious ependymitis usually features thin linear enhancment along the margins of the ventricles.
Primary glial tumor may cause periventricular enhancement.
Multiple sclerosis may affect the subependymal surface. Although the majority of demyelinating lesions do not enhance, an active plaque may demonstrate enhancement.
Gyriform enhancement (intra-axial)
Superficial enhancement of the cortical (gyral) surface of the brain can be due to either cerebral infection, inflammation, or ischemia.
Herpes encephalitis is a serious necrotizing infection of the brain parenchyma due to reactivation of latent HSV-1 infection within the trigeminal ganglion. The medial temporal lobes and cingulate gyrus are usually affected first and demonstrate gyral enhancement due to inflammation, petechial hemorrhage, and resultant BBB breakdown. The involved areas typically also demonstrate reduced diffusivity.
Meningitis may cause gyral enhancment in addition to the more typical leptomenigneal enhancement (subsequently discussed).
Subacute infarct can demonstrate gyriform enhancement lasting approximately 6 days to 6 weeks after the initial ischemic event.
In contrast to the gyriform enhancement of subacute infarct, an acute infarct may demnonstrate vascular enhancement due to reactive collateral vasodilation and resultant hyperemia.
Posterior reversible encephalopathy syndrome (PRES) is a syndrome of vasogenic white matter edema triggered by altered autoregulation that may demonstrate gyral enhancment. PRES may rarely exhibit restricted diffusion.
Nodular subcortical enhancment (intra-axial)
Nodular intra-axial enhancement is most commonly due to metastatic disease.
Hematogenously disseminated metastatic disease is commonly found at the subcortical gray-white junctions. Tumor emboli become “stuck” at the junction between the simple vasculature of the white matter and the highly branching vasculature of the gray matter.
Edema is almost always present with metastatic disease of the gray-white junction, although slightly more distal cortical metastases (e.g. pelvic malignancy spread via the Batson preverterbral venous plexus) leads to posterior fossa disease by transit through the retroclival venous plexus.
Ring enhancement (intra-axial)
Peripheral (ring) enhancment is a common presentation with a broad range of differential diagnoses. The two most common causes are high-grade neoplasm and cerebral abscess.
The mnemonic MAGIC DR (metastasis, abscess, glioma, infarct, contusion, demyelination, and radiation) may be helpful to remember the wide range of etiologies for ring enhancement, although it is usually possible to narrow the differential basedon the pattern of ring enhancement combined with additional MRI sequences and clinical history.
Metastasis: Hematogenous metastases are typically found at the subcortical gray-white junction. Metastases are often multiple, but smaller lesions may not be ring-enhancing.
Abscess: A pyogenic abscess is formed as a result of organization and sequestration of an infection, featuring a central region of viscous necrosis.
The key imaging findings of abscess are reduced diffusivity (bright on DWI and dark on ADC) caused by high viscosity of central necrosis and a characteristic smooth, hypointense rim on T2-weighted images.
Glioma: High grade tumors such as glioblastoma typically have a thick and irregular wall.
Multivoxel MRI spectroscopy will be abnormal outside the margin of an enhancing high grade glial neoplasm secondary to nonenhancing infiltrative tumor. This is in contrast to a demyelinating lesion, abscess, and metastasis, where the spectral pattern returns to normal at the margin of the lesion.
Perfusion MRI demonstrates elevated perfusion in a high grade glioma.
Infarct: Although subacute cortical infarcts often demonstrate gyral enhancment, ring enhancement can be seen in subacute basal ganglia infarcts.
In contrast to neoplasm and infection, a subacute infarct does not have significant mass effect.
Contusion: Both traumatic and nontraumatic intraparenchymal hemorrhage can show ring enhancement in the subacute to chronic stage.
Demyelinating disease: The key finding in ring-enhancing demyelinating disease is lack of significant mass effect. The “ring” of enhancement is often incomplete and “C” shaped.
Multiple sclerosis is the most common demyelinating disease. Enhancement suggests active disease.
Although the typical finding is an incomplete rim of enhancement, tumefactive demyelinating disease can look identical to a high-grade tumor.
Radiation necrosis may look identical to a high-grade tumor. On perfusion, cerebral blood volume is generally low in radiation necrosis and typically increased in a high grade glioma.
Pachymeningeal (dural) enhancement (extra-axial)
The pachymeninges (pachy means thick - a “thick-skinned” elephant is a pachyderm) refers to the dura mater, the thick and leather-like outermost covering of the brain.
In addition to surrounding the surface of the brain, the dura forms several reflections, including the falx, tentorium, and cavernous sinus.
The dura does not have a blood brain barrier. Although contrast molecules normally diffuse into the dura on enhanced CT or MRI, dural enhancement is never visualized on CT and is only viscualized on MRI in pathologic situations.
Dural enhancement is not seen on CT because both the skull and adjacent enhancing dura appear white.
Enhancement of normal dura is not visible on MRI because MRI visualization of enhancement requires both water protons and gadolinium. Although gadolinium is present in the dura, there are normally very few water protons. However, dural pathology often causes dural edema, which provides enough water protons to make the gadolinium visible. Therefore, dural enhancement on MRI is an indication of dural edema rather than BBB breakdown.
Differential diagnosis of pachymeningeal enhancement
Intracranial hypotension: Prolonged decrease in cerebrospinal fluid pressure can lead to vasogenic edema in the dura.
Intracranial hypotension clinically presents as a postural headache exacerbated by standing upright.
Intracranial hypotension may be idiopathic or secondary to CSF leak from surgery or lumbar puncture.
Imaging shows thick, linear dural enhancement, enlargement of the pituitary gland, and “sagging” of the cerebellar tonsils. There may also be subdural hemorrhage due to traction effect on the cerebral veins.
Postoperative: Dural enhancment may be seen postoperatively.
Post lumbar puncture: Diffuse dural enhancement is occasionally seen (<5% of the time) after routine lumbar puncture.
Meningeal neoplasm, such as meningioma, can produce a focal area of dural enhancement called a dural tail, due to reactive changes in the dura. Metastatic disease to the dura, most commonly breast cancer in a female and prostate cancer ina male, can cause irregular dural enhancement.
Granulomatous disease, including sarcoidosis, tuberculosis, and fungal disease, can produce dural enhancement, typically of the basal meninges (meninges of the skull base).
Leptomeningeal (pia-arachnoid) enhancement (extra-axial)
The leptomeninges (lepto means thin or narrow) include the pia and arachnoid.
Leptomeningeal enhancment follows the undulating contours of the sulci as it includes enhancement of both the subarachnoid space and the pial surface of the brain.
The differential diagnosis of FLAIR hyperintensity in the subarachnoid space overlaps with the differential for leptomeningeal enhancement. Subarachnoid FLAIR hyperintensity may be due to:
Meningitis and leptomeningeal carcinomatosis both have increased subarachnoid FLAIR signal and leptomeningeal enhancement
Subarachnoid hemorrhage manifests as increased subarachnoid FLAIR signal, without leptomeningeal enhancement. Blooming artifact on GRE and SWI from blood products will help differentiate subarachnoid hemorrhage from carcinomatosis.
Subarachnoid FLAIR signal is artifactually increased when the aptient is on oxygen or propofol therapy, without abnormal enhancement.
Differential diagnosis of leptomeningeal enhancment
Meningitis (either bacterial, viral, or fungal) is primary consideration when leptomeningeal enhancment is seen.
Leptomeningeal enhancment in meningitis is caused by BBB breakdown due to inflammation or infection.
Fine, linear enhancement suggests bacterial or viral meningitis.
Thicker, nodular enhancment suggests fungal meningitis.
Leptomeningeal carcinomatosis, also called carcinomatous meningitis, is spread of neoplasm into the subarachnoid space, which may be due to primary brain tumor or metastatic disease.
CNS neoplasms known to cause leptomeningeal carcinomatosis include medulloblastoma, oligodendroglioma, chroid plexus tumor, lymphoma, ependymoma, glioblastoma, and germinoma. Mnemonic MOCLEGG or GEMCLOG
Metastatic tumros known to cause carcinomatosis include lymphoma and breast cancer.
Viral encephalitis may produce cranial nerve enhancement within the subarachnoid space.
Slow vascular flow may mimic leptomeningeal enahcnement at first glance, but a careful examination shows the distinction. Slow flow appears as an intravascular distribution of FLAIR hyperintesity due to “unmasking” of the inherent high signal of blood, which remains int eh plane of imaging as the entire pulse sequence is obtained.
Slow flow of peripheral vessels in moyamoya disease causes the ivy sign.
Tumor-related complications
The three emergent complications of a brain tumor are the three H’s: Hemorrhage, Hydrocephalus, and Herniation. CT is a good screening method to evaluate for these complications.
Hemorrhage: Primary or metastatic brain tumors are often associated with neovascularity and tumoral vessels are more prone to hemorrhage than normal vasculature.
The most common primary brain tumor to hemorrhage is a glioblastoma.
Hemorrhagic metastases include melanoma, renal cell carcinoma, thyroid carcinoma, and choriocarcinoma. Although breast and lung cancer metastases are less frequently hemorrhagic on a case-by-case basis, these two malignancies are so common that they should also be considered in the differential of a hemorrhagic metastasis.
Mass intra- or extra-axial
After evaluation for emergent complications, the next step is to determine if the lesion in intra- or extra-axial. This distinction can sometimes be quite tricky.
Although metastases may be either intra- or extra-axial, the differential diagnosis for each space is otherwise completely different.
Findings of an extra-axial mass include a CSF cleft between the mass and the brain, buckling of gray matter, and gray matter interposed between the mass and white matter.
Findings of an intra-axial mass include absence of intervening gray matter between the mass and the white matter.
The presence of white matter edema is not specific to intra-axial masses. In particular, meningioma (an extra-axial dural neoplasm) is known to cause white matter edema of underlying brain.
Meningeal enhancement is seen more commonly in extra-axial masses (most commonly meningioma), but can also be seen in intra-axial masses.
Tumors hypointense on T2-weighted images include
Metastases containing desiccated mucin, such as some gastrointestinal adenocarcinomas. Not that mucinous metastases to the brain can have variable signal intensities on T2-weighted images, depending on the water content of the mucin. Hydrated mucin is hyperintense on T2-weighted images.
Hypercellular tumors, including lymphoma, medulloblastoma, germinoma, and some glioblastomas.
Tumors hyperintense on T1-weighted images include
Metastatic melanoma (melanin is hyperintense on T1-weighted images).
Fat-containing tumors, such as dermoid or teratoma.
Hemorrhagic metastasis (including renal cell, thyroid, choriocarcinoma, and melanoma).
Some tumors contain cystic compoments which are isointense to CSF on all sequences. (Note that cysts tend to be at the peripherey of enhancing low grade tumors. In contrast, although intra-tumoral necrosis of a high-grade tumor may also follow CSF signal, necrosis tends to be surrounded by enhancing tumor.
Glial Cells
A glioma is a primary CNS tumor that arises from a glial cell. Glial cells include astrocytes, oligodendrocytes, ependymal cells, and choroid plexus cells.
Glioma is not a synonym for a “brain tumor”. Only a tumor that arises from one of the aforementioned glial cells can accurately be called a glioma.
The normal functions of an astrocyte are to provide biochemical support to the endothelial cells that maintain the blood brain barrier, to maintain extracellular ion balance, and to aid in repair after a neurona injury.
Astrocytes are normally located throughout the entire brain (primarily in the white matter) and spinal cord.
The normal funnction of an oligodendrocyte is to maintain myelin around CNS axons. A single oligodendrocyte can maintain the myelin of dozens of axons. The counterpart in the peripheral nervous system is the Schwann cell, which maintains myelin around a single peripheral nerve. Unlike the oligodendrocyte, each Schwann cell is in charge of only a single axon.
Oligodendrocytes are normally located throughout the entire brain and spinal cord.
The normal function of an ependymal cell is to circulate CSF with its multiple cilia.
Ependydmal cells line the ventricles and central canal of the spinal cord.
The normal function of a choroid plexus cells is to produce CSF. A choroid plexus cell is a modified ependymal cell.
Choroid plexus cells are located intraventricularly, in the body and temporal horn of each lateral ventricle, roof of the third ventricle and roof of the fourth ventricle.
Grade I Astrocytoma
Juvenile pilocytic astrocytoma (JPA)
Juvenile pilocytic (hair-like) astroctyoma (JPA) is a benign World Health Organization (WHO) grade I tumor seen typically in the posterior fossa in children.
Imaging shows a well-circumscribed cystic mass with an enhancing nodule and relatively little edema. When in the posterior fossa, JPA may compress the fourth ventricle.
JPA can also occur along the optic pathway, with up to 1/3 of optic pathway JPA associated with neurofibromatosis type 1. Posterior fossa JPA is not associated with NF1.























